Kelonia Therapeutics brings to Eli Lilly an in vivo cell therapy in early clinical development for multiple myeloma. The deal complements Lilly’s acquisitions of Verve Therapeutics and Orna Therapeutics in the past year, each taking different approaches to developing in vivo genetic medicines. The post Eli Lilly Makes Another In Vivo Genetic Medicines Move With…
Health insurance makes up 8% of total employee compensation on average, and while most employees take up health insurance when it is offered, lower-wage workers are far less likely to be able to access coverage, according to an analysis of survey data and focus groups with more than 100 U.S. employers with over a quarter…
Kristin MacGregor, Ph.D., National Clinical Director for Integrated Behavioral Health at LifeStance, talks about a partnership with a large primary care medical group
OSHA and NIOSH recommend that all hospitals develop comprehensive violence prevention programs. Here are some action items that provide a framework for building a legally defensible program. The post OSHA’s Evolving Approach to Workplace Violence Prevention in Healthcare appeared first on MedCity News.
When patients disengage, preventive care is missed, chronic conditions worsen, care shifts to higher-cost settings such as the emergency department and urgent care, and patients fragment across systems, reducing continuity. The post Stopping Patient Attrition Before it Starts: A Proactive Approach to Healthcare Marketing appeared first on MedCity News.
BRISTOL, Conn. — Many hospital systems in Connecticut have stopped suing their patients over unpaid bills, stung by criticism about the harm caused by aggressive collection tactics. But physicians, dentists, ambulance companies, and other health care providers are still taking their patients to court, a Connecticut Mirror-KFF Health News investigation of state legal records shows….
Depending on whom you ask, Alfred Engelberg could be a hero or a villain in the story of American pharmaceuticals. The patent lawyer helped write legislation that led to a dramatic increase in the number of generic drugs on the market. He also contributed to a patent system that gives pharmaceutical companies monopolies on their…
Peter Stetson is the CMIO of Tiger Connect. It’s now calling itself an AI platform to connect people, especially workflows between doctors, nurses, EMTs and devices. Until recently he was CMIO at Memorial Sloan Kettering, so I asked him about what the real problems in communications were. He believes it’s all about routing the calls…
Himanshu Shah, an activist investor and large shareholder of Novavax, whose stock has plummeted over the years, believes the company should cut costs more aggressively, reduce the size of its board, and do more to prop up its financial performance. But are the criticisms valid? The post Is Shah Capital’s Criticism of Novavax Fair? A…
Obsidian Therapeutics aims to show its TIL cell therapy has advantages over an Iovance Biotherapeutics TIL therapy marketed for treating melanoma. Obsidian’s merger with Galera Therapeutics will give it a public listing and a private placement to support clinical development of the combined company’s cancer drug pipeline. The post Obsidian, Galera Merger Comes With $350M…